Kadmon Holdings, Inc. Announces Appointment of Tasos G. Konidaris as Interim Chairman of the Board
January 04, 2019 at 04:15 pm EST
Kadmon Holdings, Inc. announced that Tasos G. Konidaris, a member of Kadmon’s board of directors, has been appointed interim chairman, effective immediately. Mr. Konidaris has significant experience in the biotechnology industry, including serving as Executive Vice President and Chief Financial Officer of Alcresta Therapeutics, Inc. since March 2016 and as a senior advisor of Athyrium Capital Management, L.P. since September 2015. Previously, Mr. Konidaris held senior financial and operational roles at Ikaria, Dun & Bradstreet, Schering-Plough, Pharmacia, Rhone-Poulenc Rorer, Novartis and Bristol-Myers Squibb.